OC-2025-130285 Automated External Defibrillator   2

Background
The U.S. Food and Drug Administration (FDA), through its Office of Occupational Safety and Health (OOSH), is seeking to procure Automated External Defibrillator (AED) units and associated components as part of its nationwide Public Access Defibrillation (PAD) Program. The goal of this contract is to enhance employee and visitor safety by ensuring the availability and maintenance of AEDs across FDA facilities.

Work Details
The contractor will provide FDA-approved biphasic escalating waveform AED units with real-time CPR feedback and self-diagnostic capabilities. The contract includes the following deliverables:

- Replacement of approximately 400 AED units over fiscal years 2025 and 2026, including:
- Base Year: 237 AED Units, 385 Primary PAD PAK & Batteries, 375 Secondary PAD PAK & Batteries, 2 Pediatric PAD PAK & Batteries.
- Option Year 1: 162 AED Units, 14 Primary PAD PAK & Batteries, 16 Secondary PAD PAK & Batteries.
- Associated components such as responder kits, storage cabinets, signage, and inspection tags.
- Ongoing preventive maintenance and monitoring services.
- CPR/AED training for up to 500 FDA personnel annually in accordance with American Heart Association (AHA) or American Red Cross (ARC) standards.
- 24/7 technical support and post-event data retrieval services.

Place of Performance
Various FDA locations across 87 cities in 34 states and U.S. territories.